SCHEMBL1584528

SCHEMBL1584528

Cc1ccc(CC(=O)O)cc1OCc1c(C)ccc(O)c1C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 3/20 0.74
GAA P10253 4/20 0.54
TSHR P16473 3/20 0.54
NFKB1 P19838 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
ALDH1A1 P00352 1/20 0.54
KDM4E B2RXH2 1/20 0.46
RGS12 O14924 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
APEX1 P27695 1/20 0.46
THPO P40225 1/20 0.46
BLM P54132 1/20 0.46
GNAI1 P63096 1/20 0.46
PMP22 Q01453 1/20 0.46
HIF1A Q16665 1/20 0.46
HSD17B10 Q99714 1/20 0.46
RXRA P19793 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1584780 0.86 SLC22A12 (0.55) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL1584507 0.86 SLC22A12 (0.72) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL460443 0.85 SLC22A12 (1.00) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL1584589 0.83 SLC22A12 (0.67) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL1584592 0.82 SLC22A12 (0.66) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL7897205 0.77 SLC22A12 (0.67) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL334173 0.75 SLC22A12 (0.63) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL956632 0.74 SLC22A12 (0.78) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL955065 0.74 SLC22A12 (0.78) SLC22A12GAATSHRNFKB1TDP1
SCHEMBL1010618 0.74 GAA (0.70) SLC22A12GAATSHRNFKB1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488020-B1 3-SUBSTITUTED COMPOUNDS FOR REDUCING URIC ACID WELLSTAT THERAPEUTICS CORP (US) 2016-12-14 EP claimed
US-8546448-B2 3-substituted compounds for reducing uric acid WELLSTAT THERAPEUTICS CORPORATION (US) 2013-10-01 US claimed
EP-2488020-A1 3-SUBSTITUTED COMPOUNDS FOR REDUCING URIC ACID Wellstat Therapeutics Corporation (US) 2012-08-22 EP claimed
WO-2011046800-A1 3-SUBSTITUTED COMPOUNDS FOR REDUCING URIC ACID WELLSTAT THERAPEUTICS CORPORATION (US) 2011-04-21 WO claimed
EP-2488020-B1 3-SUBSTITUTED COMPOUNDS FOR REDUCING URIC ACID WELLSTAT THERAPEUTICS CORP (US) 2016-12-14 EP disclosed
EP-2488020-A1 3-SUBSTITUTED COMPOUNDS FOR REDUCING URIC ACID Wellstat Therapeutics Corporation (US) 2012-08-22 EP disclosed
WO-2011046800-A1 3-SUBSTITUTED COMPOUNDS FOR REDUCING URIC ACID WELLSTAT THERAPEUTICS CORPORATION (US) 2011-04-21 WO disclosed